Hui Zhao

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

|Apr 21, 2026
A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

|Dec 22, 2025
Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance.

Jie Gao, Nan Bai, Mingyu Liu

|Jul 15, 2024
Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization.

Saiyan Bian, Wenkai Ni, Linlin Zhou

|Oct 10, 2022
A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE.

Zicong Xia, Wenjing Zhao, Jibin Liu

Pageof 1

Frequent Collaborators

4 joint publications

Wenjie Zheng

2 joint publications

Yifu Xiao

1 joint publications

Zicong Xia

1 joint publications

Wenjing Zhao